The End of M2 Year

3:53 PM

Author | Erica Prochaska

This week was the last week of M2 year. I took my last final of the preclinical years yesterday and am not tying up some loose ends before beginning to study for step 1. I was talking with a friend who is getting her PhD in Environmental Science this morning. She asked me how med school was going and I told her that it was not as bad as I thought it would be. She said that it seemed like I must be a natural fit for it, but I explained that Michigan made it very easy to feel at home even when I was struggling to memorize biochemical pathways or trying to make it through all the reading for M2 neurology. Medical school is hard no matter what, and it should be hard. But I've made amazing friends over my first two years of medical school and I've learned a surprising amount. I am nervous about the boards and the five weeks of studying that I have ahead of me. Nevertheless, I'm also so excited about the clinical years. All of my third and fourth year friends say that the clinical years are by far the most fun and interesting of medical school. As a non-traditional student, going back to lecture was difficult for me. I'm looking forward to using different skills when I'm on the wards. I'm also so proud of our class for pushing through the first half of medical school together.

The fourth year medical students matched on Friday. Two years form now, my classmates and I will know where we are going to do our residencies. We are all curious to see what the next two years will be like, and I am optimistic that we will all continue to work hard together to learn how to take care of people.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories orange cells floating squiggly lines coming out of it with blurred blue and purple colors
Health Lab
Clinically deployed AI guidance for preventing C. difficile spread
AI guidance for clinicians aimed at reducing the spread of C.diff was deployed for the first time in a hospital setting, according to a University of Michigan-led study.
Lian Chen and Tim Johnson
Department News
After time at UMMS, visiting scholar publishes call for more leadership training in China
After completing a UMMS leadership program, a visiting doctor from China is encouraging healthcare leaders in her home country to launch similar training initiatives.
Well-Being at Michigan Medicine podcast - a part of the Michigan Medicine Podcast Network.
Well-Being at Michigan Medicine
Environmental sustainability and its effects on well-being
Dr. Elizabeth Harry welcomes Chip Amoe, U-M Health’s Chief Sustainability Officer, who shares how his Michigan roots and passion for revitalizing communities inspired his career in health care sustainability.
outline drawing of pancreas on beige screen with green orange yellow and pink
Health Lab
Avoiding recovery delays with hospitalized pancreatitis
Acute pancreatitis is among the most common gastrointestinal conditions requiring inpatient hospital care in the United States. Balancing the signaling of the interleukin-22 protein and interleukin-22 binding protein is crucial to recovery from acute and chronic pancreatitis.
Black man wearing glasses, a dark blue suit coat and bow tie
Department News
Dr. Feranmi Okanlami joins NIH Working Group to guide efforts in advancing disability health research
Dr. Feranmi Okanlani has been invited to join the NIH Working Group for Disability Research
What I'm Reading in APS Research
Department News
What I'm Reading in APS Research: June 2025
What I’m Reading in APS Research, written by Dr. Ajay Tambralli, was created to provide information about some of the latest APS research and to help everyone better understand the ins and outs of new discoveries. In this month’s edition, Dr. Tambralli explores the amazing properties of camelid antibodies and their potential applications in future therapies.